Showing results (21-30 of 112) with videos related to
Sort By:
Pageof 12
Cancer Management and Research|May 13, 2022
Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via TelemedicineKatarína Hradská, Tereza Popková, Michaela Skořupová, et al.Leukemia Research|June 7, 2008
Nuclear organization of PML bodies in leukaemic and multiple myeloma cellsJana Krejcí, Andrea Harnicarová, Jana Kůrová, et al.International Journal of Molecular Sciences|November 27, 2021
GM3 Ganglioside Linked to Neurofibrillary Pathology in a Transgenic Rat Model for TauopathyDominika Olešová, Petra Majerová, Roman Hájek, et al.Journal of Negative Results in Biomedicine|September 25, 2015
MicroRNAs in urine are not biomarkers of multiple myelomaLenka Sedlaříková, Lenka Bešše, Soňa Novosadová, et al.Oncology and Therapy|July 24, 2020
Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed SettingWalter Bouwmeester, Andrew Briggs, Ben van Hout, et al.European Journal of Haematology|September 9, 2017
Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflectionKateřina Growková, Elena Kryukova, Zuzana Kufová, et al.Cells|February 11, 2023
Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone DiseaseSandra Charvátová, Benjamin Motais, Justyna Czapla, et al.Cancers|May 28, 2020
A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood CancersBenjamin Motais, Sandra Charvátová, Matouš Hrdinka, et al.Vnitrni Lekarstvi|September 18, 2020
Osteolytic bone lesions, hypercalcemia and paraprotein, but not a myeloma: case report and review of literatureKatarína Hradská, Tomáš Jelínek, Juraj Ďuraš, et al.BMJ Open|July 16, 2020
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart reviewRoman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, et al.Pageof 12